Paul Lipkin, M.D.

Kennedy Krieger Institute
707 N. Broadway
Baltimore, MD 21205
Phone: (443) 923-3240
Email: lipkin@kennedykrieger.org

Dr. Paul Lipkin is the director of the Center for Development and Learning at the Kennedy Krieger Institute. Dr. Lipkin is also an associate professor of pediatrics at the Johns Hopkins University School of Medicine.

Biographical Sketch:

Dr. Lipkin received his undergraduate degree from Rutgers University and attended medical school at the University of Medicine and Dentistry of New Jersey - New Jersey Medical School. He received his general pediatric training, focusing on primary care, at Sinai Hospital of Baltimore, followed by subspecialty training in developmental pediatrics at Johns Hopkins University and the Kennedy Krieger Institute.

Dr. Lipkin joined the faculty of the Kennedy Krieger Institute and Johns Hopkins University in 1995, and today serves as the director of the Center for Development and Learning in the Department of Neurology and Developmental Medicine. He is board-certified in pediatrics, neurodevelopmental disabilities, and developmental and behavioral pediatrics. At the Institute, Dr. Lipkin oversees the clinical program for the diagnosis and treatment of children with neurodevelopmental disabilities, including autism, attention, learning, and language disorders. He serves on the faculty of the Institute's Leadership Education in Neurodevelopmental Disabilities (LEND) program, as well as the medical school's pediatrics programs.

Research Summary:

Dr. Lipkin's career has focused on the early identification and treatment of neurodevelopmental disorders in infants and children. He is currently active on initiatives centered on developmental and autism screening in the general population as well as high-risk children, such as those with alcohol-related neurodevelopmental disorder, congenital heart disease, and motor disorders. He has recently served on consensus panels examining methods of neurodevelopmental evaluation of children exposed to polychlorinated biphenyls and other neurotoxins (Cefic- Long-range Research Initiative) and on recognition of Alcohol-Related Neurodevelopmental Disorder (US Interagency Coordinating Committee on Fetal Alcohol Disorders).

Dr. Lipkin is past Chair of the American Academy of Pediatrics (AAP) Council on Children with Disabilities, where he led educational and policy initiatives aimed at improved identification and care of children with disabilities. He also chaired key AAP initiatives aimed at increasing early developmental surveillance and screening. The AAP awarded Dr. Lipkin with the Arnold J. Capute Award in 2011 in recognition of his work on behalf of children with disabilities. He also served in 2010-2011 as a Robert Wood Johnson Foundation Health Policy Fellow in the Office of the U.S. Secretary of Health and Human Services Kathleen Sebelius.

To request an appointment, please contact the Kennedy Krieger Institute Intake Line at (443) 923-9200, toll-free at (888) 554-2080, or TTY (443) 923-2645.

LINK: SciVal Experts Research Profile for Paul Lipkin

Publications:

Should all children be screened for autism spectrum disorders? Yes: merging science, policy, and practice.
Lipkin PH, Hyman SL.
Am Fam Physician. 2011 Aug 15;84(4):361-7. No abstract available.

Learning disabilities and school failure.
Rimrodt SL, Lipkin PH.
Pediatr Rev. 2011 Aug;32(8):315-24. Review.

Implementing developmental screening and referrals: lessons learned from a national project.
King TM, Tandon SD, Macias MM, Healy JA, Duncan PM, Swigonski NL, Skipper SM, Lipkin PH.
Pediatrics. 2010 Feb;125(2):350-60. Epub 2010 Jan 25.